Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment (2022)
- Authors:
- USP affiliated authors: ISHIDA, KELLY - ICB ; WIRTH, FERNANDA - ICB
- Unidade: ICB
- DOI: 10.2217/fmb-2021-0291
- Subjects: MICROBIOLOGIA; CIÊNCIA DA COMPUTAÇÃO; ANTIFÚNGICOS; CRIPTOCOCOSE; MODELOS ANIMAIS; FARMACODINÂMICA; MICOSES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Microbiology
- ISSN: 1746-0921
- Volume/Número/Paginação/Ano: p. 1-14, 2022
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
WIRTH, Fernanda et al. Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment. Future Microbiology, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.2217/fmb-2021-0291. Acesso em: 02 abr. 2026. -
APA
Wirth, F., Staudt, K. J., Araújo, B. V., & Ishida, K. (2022). Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment. Future Microbiology, 1-14. doi:10.2217/fmb-2021-0291 -
NLM
Wirth F, Staudt KJ, Araújo BV, Ishida K. Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment [Internet]. Future Microbiology. 2022 ; 1-14.[citado 2026 abr. 02 ] Available from: https://doi.org/10.2217/fmb-2021-0291 -
Vancouver
Wirth F, Staudt KJ, Araújo BV, Ishida K. Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment [Internet]. Future Microbiology. 2022 ; 1-14.[citado 2026 abr. 02 ] Available from: https://doi.org/10.2217/fmb-2021-0291 - Three-dimensional lung parenchyma model for studies of aspergillus fumigatusinfection and antifungal treatment
- Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms
- Amphotericin B, alone or followed by itraconazole therapy, is effective in the control of experimental disseminated sporotrichosis by Sporothrix brasiliensis
- Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole
- Characterization of Candida spp. isolated from vaginal fluid: identification, antifungal susceptibility, and virulence profile
- Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis
- Δ(24)-sterol methyltransferase plays an important role in the growth and development of Sporothrix schenckii and Sporothrix brasiliensis
- Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil
- Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine
- Adamantylidene-substituted alkylphosphocholine TCAN26 is more active against Sporothrix schenckii than miltefosine
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
